About half of U.S. adults have high blood pressure and too few have it under control. Now some patients who've tried ...
Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do ...
People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.
The Centers for Medicare & Medicaid Services announced 15 new drugs it wants to lower the cost for, including popular, but ...
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...
Current laws and regulations are not enough to protect Americans from the risks of compounded versions of popular weight loss ...
A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...
The Food and Drug ... weight-loss medications have garnered immense national attention and ignited a debate about access and demand for the drugs, which help people shave pounds. The FDA first ...
The U.S. Food and Drug Administration (FDA) has granted approval for Zepbound, a weight-loss medication ... Zepbound’s new indication highlights its broader therapeutic potential.
Tryngolza (olezarsen) has been approved by the U.S. Food and Drug ... with a diet including ≤20 g fat per day. Tryngolza is self-administered once monthly via an autoinjector. The FDA approval ...
WASHINGTON — The U.S. Food and Drug Administration on Friday approved Eli Lilly's weight-loss treatment ... can expand approval for medicines if new data shows them to be effective in other ...